XML 16 R4.htm IDEA: XBRL DOCUMENT v3.21.2
Consolidated Statements of Operations - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Operating expenses:        
Research and development $ 13,180,258 $ 14,795,493 $ 44,279,272 $ 52,859,850
General and administrative 20,226,884 6,331,308 47,819,618 18,537,242
Total operating expenses 33,407,142 21,126,801 92,098,890 71,397,092
Loss from operations (33,407,142) (21,126,801) (92,098,890) (71,397,092)
Interest and amortization of debt discount (expense) income (1,475,535) (551,002) (4,327,966) (1,091,849)
Loss on extinguishment of debt   (1,247,012)   (1,247,012)
Net loss $ (34,882,677) $ (22,924,815) $ (96,426,856) $ (73,735,953)
Net loss per common share, basic and diluted $ (0.93) $ (0.61) $ (2.57) $ (1.98)
Weighted average common shares outstanding, basic and diluted 37,680,966 37,311,726 37,569,416 37,158,513